ClinConnect ClinConnect Logo
Search / Trial NCT05344911

Comparison of Postoperative Pain Application of Alfentanil or Remifentanil in TIVA

Launched by XIJING HOSPITAL · Apr 18, 2022

Trial Information

Current as of June 04, 2025

Completed

Keywords

Functional Endoscopic Sinus Surgery Postoperative Pain Afentanil Or Remifentanil

ClinConnect Summary

This study intends to observe the effect of TIVA using afentanil or remifentanil on postoperative pain in patients undergoing functional nasal endoscopic surgery under general anesthesia.

Main indicators:

VAS score at 30 min after operation.

Secondary indicators:

VAS score of 60 min after operation. VAS score of 24h after operation. Number of cases of postoperative use of analgesics . Number of cases of postoperative adverse reactions.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Age 18-65 years old
  • ASA Ⅰ-Ⅲ
  • patients undergoing functional endoscopic sinus surgery under general anesthesia.
  • Exclusion Criteria:
  • Significant hypertension (diastolic blood pressure \> 100mmHg) or hypotension (systolic . blood pressure \< 100mmHg).
  • severe mental, cardiovascular, kidney or liver disease.
  • previous history of alcohol or drug abuse.
  • long-term use of painkillers before operation.
  • contraindications for any drugs used in the study.

About Xijing Hospital

Xijing Hospital, a prominent medical institution affiliated with the Fourth Military Medical University in Xi'an, China, is dedicated to advancing healthcare through innovative clinical research. Renowned for its comprehensive range of medical services and expertise in various specialties, Xijing Hospital actively sponsors clinical trials aimed at evaluating new therapies, improving patient outcomes, and contributing to scientific knowledge. With a commitment to ethical standards and patient safety, the hospital fosters collaboration among multidisciplinary teams to drive forward the development of effective treatment options that address critical health challenges.

Locations

Xian, Shanxi, China

Patients applied

0 patients applied

Trial Officials

Yan Jia

Principal Investigator

The First Affiliated Hospital of the Air Force Medical Universtiy

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials